SAN DIEGO, CA— Use of intranasal mupirocin as a strategy to prevent methicillin-resistant Staphylococcus aureus (MRSA) in the neonatal intensive care unit (NICU) is limited by a 50% recolonization ...

Please provide your email address to receive an email when new articles are posted on . Mupirocin treatment effectively induced primary Staphylococcus aureus decolonization in 85% to 100% of infants ...

A team of doctors has performed a clinical trial involving multiple hospitals that tested the effectiveness of applying a topical antibiotic known as mupirocin for prevention of Staphylococcus aureus ...

Researchers conducted the study between April 2014 and May 2016 at eight NICUs. Infants younger than two years old underwent serial screening for nasal Staphylococcus aureus. Those colonized with ...

Please provide your email address to receive an email when new articles are posted on . “Mupirocin is the gold-standard topical treatment for nasal decolonization, but there are reports of increasing ...

A large multi-state study by the Centers for Disease Control and Prevention, the Harvard Pilgrim Health Care Institute, HCA Healthcare, and the University of California, Irvine has found that a nasal ...

Staphylococcus aureus is a known complication of atopic dermatitis, and treatment of S aureus can improve this condition. Nasal swabbing with mupirocin ointment is somewhat effective in reducing nasal ...

Topical application of medical-grade antibacterial honey to the catheter exit-site is not more effective than standard exit-site care with additional intranasal mupirocin in carriers of Staphylococcus ...

VANCOUVER, Canada--(BUSINESS WIRE)--Following its successful fundraising of C$4.91 million (US$3.62), Canadian life sciences company Ondine Biomedical Inc. will continue accelerating commercialisation ...

BALTIMORE, MD, Dec. 26, 2018 -- A team of doctors led by Karen L. Kotloff, M.D., University of Maryland School of Medicine (UMSOM), Center for Vaccine Development and Global Health (CVD), has ...